These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 7632778)
21. Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging. Erfani M; Shamsaei M; Mohammadbaghery F; Shirmardi SP J Labelled Comp Radiopharm; 2014 May; 57(6):419-24. PubMed ID: 24737145 [TBL] [Abstract][Full Text] [Related]
22. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis. Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883 [TBL] [Abstract][Full Text] [Related]
23. In vivo assessment of 99mTc-labeled hematoporphyrin derivative in tumor-bearing animals. Wong DW; Mandal A; Reese IC; Brown J; Siegler R Int J Nucl Med Biol; 1983; 10(4):211-8. PubMed ID: 6319312 [TBL] [Abstract][Full Text] [Related]
27. Physiological modeling of disposition of potential tumor-imaging radiopharmaceuticals in tumor-bearing mice. Bourne DW; Jacobs JJ; Awaluddin A; Maddalena DJ; Wilson JG; Boyd RE J Pharm Sci; 1992 May; 81(5):408-12. PubMed ID: 1403669 [TBL] [Abstract][Full Text] [Related]
28. Biodistribution and kinetics of radiolabelled pyrrolidino-4-iodo-tamoxifen: prospects for pharmacokinetic studies using PET. Carnochan P; Trivedi M; Young H; Eccles S; Potter G; Haynes B; Ott R J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):96-8. PubMed ID: 7632777 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of [99mTc]ethylenedicysteine-colchicine for evaluation of antiangiogenic effect. Zareneyrizi F; Yang DJ; Oh CS; Ilgan S; Yu DF; Tansey W; Liu CW; Kim EE; Podoloff DA Anticancer Drugs; 1999 Aug; 10(7):685-92. PubMed ID: 10507319 [TBL] [Abstract][Full Text] [Related]
30. Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent. León AS; Rey AM; Leon ET; Savio EO; Kremer C; Lacava CJ; Nappa AN; Chiozzone RN; Campos ED Q J Nucl Med; 1996 Jun; 40(2):170-5. PubMed ID: 8909102 [TBL] [Abstract][Full Text] [Related]
31. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals. Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Bayhan H; Yu D; Kim EE; Podoloff DA Cancer Biother Radiopharm; 1998 Dec; 13(6):427-35. PubMed ID: 10851435 [TBL] [Abstract][Full Text] [Related]
32. Direct labeling of monoclonal antibodies with 99mTc and radioimmunodetection of a murine mammary carcinoma with 99mTc-B2C114. Duran AP; Asurmendi S; D'Orio E; Horenstein AL; de Castiglia SG J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):33-7. PubMed ID: 7632765 [TBL] [Abstract][Full Text] [Related]
33. 99mTc-labeled field bean protease inhibitor can function as an efficient tumor detecting agent. Murugesan S; Banerji AP; Noronha OP; Samuel AM; Fernandes AO Indian J Exp Biol; 2001 Aug; 39(8):742-7. PubMed ID: 12018574 [TBL] [Abstract][Full Text] [Related]
34. 99mTc-ADP: a potential agent for in vivo tumor detection. León ET; Rey AM; Savio EO; López JJ; Kremer E; León AS J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):99-103. PubMed ID: 7632778 [TBL] [Abstract][Full Text] [Related]